FATE : Fate Therapeutics stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2026-05-28 |
|---|---|---|---|---|
| 2026 | $2.42 | $2.27 | $2.61 | -8.07% |
| 2027 | $2.36 | $2.25 | $2.53 | -10.43% |
| 2028 | $2.55 | $2.52 | $2.58 | -3.1% |
| 2029 | $2.74 | $2.59 | $2.84 | 4.35% |
| 2030 | $2.9 | $2.85 | $2.97 | 10.14% |
| 2031 | $3.1 | $3.0 | $3.15 | 17.8% |
| 2032 | $3.17 | $3.16 | $3.18 | 20.51% |
| 2033 | $3.16 | $3.13 | $3.18 | 19.97% |
| 2034 | $2.97 | $2.46 | $3.12 | 12.74% |
| 2035 | $1.39 | $0.94 | $2.22 | -47.2% |
| 2036 | $0.71 | $0.59 | $0.86 | -73.03% |
The 1 Wall Street analysts offering Fate Therapeutics stock forecast in the last 6 months have average price target of
$7.0 with a high forecast of $7.0 and a low forecast of $7.0.
The average Fate Therapeutics stock forecast represents a 166.16%
increase from the last price of $2.630000114440918.
For Fate Therapeutics stock forecast for 2026, 7 predictions are offered for each month of 2026 with average Fate Therapeutics stock
forecast of $2.42, a high forecast of $2.61, and a low forecast of $2.27.
The average Fate Therapeutics stock forecast 2026 represents a -8.07%
decrease from the last price of $2.630000114440918.
For Fate Therapeutics stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Fate Therapeutics stock
forecast of $2.36, a high forecast of $2.53, and a low forecast of $2.25.
The average Fate Therapeutics stock forecast 2027 represents a -10.43%
decrease from the last price of $2.630000114440918.
For Fate Therapeutics stock forecast for 2029, 12 predictions are offered for each month of 2029 with average Fate Therapeutics stock
forecast of $2.74, a high forecast of $2.84, and a low forecast of $2.59.
The average Fate Therapeutics stock forecast 2029 represents a 4.35%
increase from the last price of $2.630000114440918.
For Fate Therapeutics stock forecast for 2031 (5 year), 12 predictions are offered for each month of 2031 with average Fate Therapeutics stock
forecast of $3.1, a high forecast of $3.15, and a low forecast of $3.0.
The average Fate Therapeutics stock forecast 2031 represents a 17.8%
increase from the last price of $2.630000114440918.
For Fate Therapeutics stock forecast 2032, 12 predictions are offered for each month of 2032 with average Fate Therapeutics stock
forecast of $3.17, a high forecast of $3.18, and a low forecast of $3.16.
The average Fate Therapeutics stock forecast 2032 represents a 20.51%
increase from the last price of $2.630000114440918.
For Fate Therapeutics stock forecast for 2036 (10 year), 5 predictions are offered for each month of 2036 with average Fate Therapeutics stock
forecast of $0.71, a high forecast of $0.86, and a low forecast of $0.59.
The average Fate Therapeutics stock forecast 2036 represents a -73.03%
decrease from the last price of $2.630000114440918.
Please, see more forecasts below.
FATE : Fate Therapeutics stock forecast by Wall Street Analysts
The average Fate Therapeutics stock forecast from last 6 month is $7.0, and this show a 40.0% increase in average from the prior price target of the each prediction. Also, this average forecast of $7.0 represents a 44.93% increase from the past average forecast of $4.83, 6 months ago from 3 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2026-05-04 | HC Wainwright & Co. | $5.0000 | $7.0000 | Buy |
| 2025-10-31 | HC Wainwright & Co. | $5.00 | $5.0000 | Buy |
| 2025-10-27 | Wedbush | $5.00 | $7.0000 | Outperform |
| 2025-10-27 | Needham | Hold | ||
| 2025-08-13 | Wells Fargo | $4.00 | $2.5000 | Equal-Weight |
Fate Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2026-05-29 | $2.70 | 2.60% |
| 2026-06-01 | $2.62 | -2.72% |
| 2026-06-02 | $2.59 | -1.51% |
| 2026-06-03 | $2.55 | -1.34% |
| 2026-06-04 | $2.53 | -0.96% |
FATE : Long term Fate Therapeutics stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2026 Jun. is $2.61 , for 2027 May. is $2.30 , for 2030 May. is $2.88 , for 2031 May. is $3.09 , for 2035 May. is $1.38 , and for 2036 May. is $.59.
FATE : Fate Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jun. | $2.61 | -0.70% |
| 2026 Jul. | $2.56 | -2.16% |
| 2026 Aug. | $2.48 | -3.08% |
| 2026 Sep. | $2.40 | -3.16% |
| 2026 Oct. | $2.33 | -2.88% |
| 2026 Nov. | $2.29 | -1.72% |
| 2026 Dec. | $2.27 | -1.02% |
FATE : Fate Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $2.25 | -0.84% |
| 2027 Feb. | $2.25 | 0.21% |
| 2027 Mar. | $2.26 | 0.59% |
| 2027 Apr. | $2.28 | 0.73% |
| 2027 May. | $2.30 | 0.80% |
| 2027 Jun. | $2.32 | 0.89% |
| 2027 Jul. | $2.35 | 1.11% |
| 2027 Aug. | $2.38 | 1.37% |
| 2027 Sep. | $2.42 | 1.59% |
| 2027 Oct. | $2.45 | 1.55% |
| 2027 Nov. | $2.49 | 1.52% |
| 2027 Dec. | $2.53 | 1.41% |
FATE : Fate Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $2.55 | 1.15% |
| 2028 Feb. | $2.57 | 0.69% |
| 2028 Mar. | $2.58 | 0.24% |
| 2028 Apr. | $2.58 | -0.12% |
| 2028 May. | $2.56 | -0.40% |
| 2028 Jun. | $2.55 | -0.40% |
| 2028 Jul. | $2.54 | -0.55% |
| 2028 Aug. | $2.53 | -0.56% |
| 2028 Sep. | $2.52 | -0.35% |
| 2028 Oct. | $2.52 | 0.03% |
| 2028 Nov. | $2.53 | 0.42% |
| 2028 Dec. | $2.55 | 0.88% |
FATE : Fate Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $2.59 | 1.71% |
| 2029 Feb. | $2.64 | 1.66% |
| 2029 Mar. | $2.68 | 1.45% |
| 2029 Apr. | $2.71 | 1.20% |
| 2029 May. | $2.73 | 0.97% |
| 2029 Jun. | $2.76 | 0.87% |
| 2029 Jul. | $2.77 | 0.45% |
| 2029 Aug. | $2.78 | 0.50% |
| 2029 Sep. | $2.80 | 0.45% |
| 2029 Oct. | $2.81 | 0.39% |
| 2029 Nov. | $2.82 | 0.58% |
| 2029 Dec. | $2.84 | 0.54% |
FATE : Fate Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $2.85 | 0.38% |
| 2030 Feb. | $2.86 | 0.25% |
| 2030 Mar. | $2.86 | 0.24% |
| 2030 Apr. | $2.87 | 0.26% |
| 2030 May. | $2.88 | 0.28% |
| 2030 Jun. | $2.89 | 0.29% |
| 2030 Jul. | $2.90 | 0.29% |
| 2030 Aug. | $2.91 | 0.30% |
| 2030 Sep. | $2.91 | 0.32% |
| 2030 Oct. | $2.93 | 0.38% |
| 2030 Nov. | $2.94 | 0.53% |
| 2030 Dec. | $2.97 | 0.84% |
FATE : Fate Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $3.00 | 1.20% |
| 2031 Feb. | $3.04 | 1.21% |
| 2031 Mar. | $3.06 | 0.89% |
| 2031 Apr. | $3.08 | 0.54% |
| 2031 May. | $3.09 | 0.33% |
| 2031 Jun. | $3.10 | 0.26% |
| 2031 Jul. | $3.11 | 0.32% |
| 2031 Aug. | $3.12 | 0.39% |
| 2031 Sep. | $3.13 | 0.36% |
| 2031 Oct. | $3.14 | 0.26% |
| 2031 Nov. | $3.15 | 0.20% |
| 2031 Dec. | $3.15 | 0.17% |
FATE : Fate Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $3.16 | 0.14% |
| 2032 Feb. | $3.16 | 0.12% |
| 2032 Mar. | $3.16 | 0.10% |
| 2032 Apr. | $3.17 | 0.08% |
| 2032 May. | $3.17 | 0.07% |
| 2032 Jun. | $3.17 | 0.06% |
| 2032 Jul. | $3.17 | 0.05% |
| 2032 Aug. | $3.17 | 0.04% |
| 2032 Sep. | $3.17 | 0.03% |
| 2032 Oct. | $3.18 | 0.02% |
| 2032 Nov. | $3.18 | 0.01% |
| 2032 Dec. | $3.18 | 0.00% |
FATE : Fate Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $3.18 | -0.01% |
| 2033 Feb. | $3.17 | -0.02% |
| 2033 Mar. | $3.17 | -0.04% |
| 2033 Apr. | $3.17 | -0.06% |
| 2033 May. | $3.17 | -0.10% |
| 2033 Jun. | $3.16 | -0.16% |
| 2033 Jul. | $3.16 | -0.25% |
| 2033 Aug. | $3.15 | -0.29% |
| 2033 Sep. | $3.14 | -0.21% |
| 2033 Oct. | $3.14 | -0.13% |
| 2033 Nov. | $3.13 | -0.12% |
| 2033 Dec. | $3.13 | -0.17% |
FATE : Fate Therapeutics stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $3.12 | -0.24% |
| 2034 Feb. | $3.11 | -0.31% |
| 2034 Mar. | $3.10 | -0.40% |
| 2034 Apr. | $3.08 | -0.49% |
| 2034 May. | $3.06 | -0.54% |
| 2034 Jun. | $3.05 | -0.54% |
| 2034 Jul. | $3.03 | -0.48% |
| 2034 Aug. | $3.02 | -0.57% |
| 2034 Sep. | $2.97 | -1.38% |
| 2034 Oct. | $2.88 | -3.23% |
| 2034 Nov. | $2.69 | -6.51% |
| 2034 Dec. | $2.46 | -8.47% |
FATE : Fate Therapeutics stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $2.22 | -9.68% |
| 2035 Feb. | $1.96 | -11.73% |
| 2035 Mar. | $1.70 | -13.51% |
| 2035 Apr. | $1.50 | -11.68% |
| 2035 May. | $1.38 | -8.27% |
| 2035 Jun. | $1.30 | -5.74% |
| 2035 Jul. | $1.24 | -4.42% |
| 2035 Aug. | $1.19 | -4.04% |
| 2035 Sep. | $1.14 | -4.29% |
| 2035 Oct. | $1.08 | -5.05% |
| 2035 Nov. | $1.01 | -6.17% |
| 2035 Dec. | $.94 | -7.48% |
FATE : Fate Therapeutics stock forecast for 2036
| Date | Price Target | Change |
|---|---|---|
| 2036 Jan. | $.86 | -8.77% |
| 2036 Feb. | $.77 | -9.66% |
| 2036 Mar. | $.70 | -9.88% |
| 2036 Apr. | $.63 | -9.15% |
| 2036 May. | $.59 | -7.61% |
Financial Data for Fate Therapeutics stock
Frequently Asked Questions about Fate Therapeutics stock forecast
Is Fate Therapeutics a good long term stock?
From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock cannot be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2026 Jun. is $2.611549662941744 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock cannot be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2027 May. is $2.2992106536769863 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock can be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2030 May. is $2.879860990034908 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock can be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2031 May. is $3.091408494379176 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock cannot be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2035 May. is $1.376223418806512 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock cannot be a good investment choice. According to AIPickup, the Fate Therapeutics stock price forecast for 2036 May. is $0.5852710379585051
Is Fate Therapeutics stock overvalued?
Fate Therapeutics (FATE) stock is expected to go DOWN . Therefore, AIPickup would say that Fate Therapeutics (FATE) stock is overvalued.
Will Fate Therapeutics stock price go up?
No. The Fate Therapeutics stock price forecast for 2027 May. is $2.2992106536769863
Is Fate Therapeutics stock a good buy now?
Since closing price on 2026-05-28 is $2.630000114440918 and forecast for 2027 May. is $2.30, Fate Therapeutics stock is not a good 1 year investment.
14 Days Historical Data for Fate Therapeutics stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| FATE stock price for 2026-05-08 | $2.39 | $2.40 | $2.32 | $2.47 |
| FATE stock price for 2026-05-11 | $2.18 | $2.36 | $2.15 | $2.43 |
| FATE stock price for 2026-05-12 | $2.25 | $2.19 | $2.06 | $2.27 |
| FATE stock price for 2026-05-13 | $2.14 | $2.19 | $1.83 | $2.22 |
| FATE stock price for 2026-05-14 | $1.90 | $2.02 | $1.90 | $2.20 |
| FATE stock price for 2026-05-15 | $1.76 | $1.86 | $1.71 | $1.91 |
| FATE stock price for 2026-05-18 | $1.73 | $1.73 | $1.69 | $1.83 |
| FATE stock price for 2026-05-19 | $1.89 | $1.70 | $1.59 | $1.91 |
| FATE stock price for 2026-05-20 | $1.84 | $1.87 | $1.83 | $1.98 |
| FATE stock price for 2026-05-21 | $2.10 | $1.79 | $1.79 | $2.15 |
| FATE stock price for 2026-05-22 | $2.25 | $2.11 | $2.09 | $2.32 |
| FATE stock price for 2026-05-26 | $2.15 | $2.28 | $2.09 | $2.31 |
| FATE stock price for 2026-05-27 | $2.37 | $2.19 | $2.15 | $2.44 |
| FATE stock price for 2026-05-28 | $2.63 | $2.37 | $2.31 | $2.67 |